Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus

ABSTRACT Using 98 clinical methicillin-susceptible Staphylococcus aureus isolates of known β-lactamase (Bla) type, we found a pronounced inoculum effect for cephalexin (mostly Bla type A and C strains), a mild inoculum effect for cephalothin (especially types B and C), and no inoculum effects for ceftriaxone and cefuroxime. Ceftobiprole showed the lowest MICs at a high inoculum but with a slight increase for Bla-positive versus Bla-negative strains. Since a potential therapeutic effect associated with a cephalosporin inoculum effect has been described, further studies are warranted.

[1]  V. Fowler,et al.  Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure , 2009, Antimicrobial Agents and Chemotherapy.

[2]  M. Page,et al.  Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D , 2007, Antimicrobial Agents and Chemotherapy.

[3]  David R. Snydman,et al.  Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes From the International Collaboration on Endocarditis Merged DatabaseMiro JM, and the International Collaboration on Endocarditis Merged Database Study Group (Univ of Barcelona; et al) Clin Infect Dis 41:507–514, 2005§ , 2006 .

[4]  Bruno Hoen,et al.  Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Fernández-Guerrero,et al.  Cefazolin therapy for Staphylococcus aureus bacteremia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Kavindra V. Singh,et al.  Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  R. Skov,et al.  In vitro susceptibility of Staphylococcus aureus towards amoxycillin‐clavulanic acid, penicillin‐clavulanic acid, dicloxacillin and cefuroxime , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[8]  J. Gavaldà,et al.  Efficacy of Ceftriaxone and Gentamicin Given Once a Day by Using Human-Like Pharmacokinetics in Treatment of Experimental Staphylococcal Endocarditis , 2002, Antimicrobial Agents and Chemotherapy.

[9]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[10]  B. Guglielmo,et al.  Ceftriaxone therapy for staphylococcal osteomyelitis: a review. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Kernodle,et al.  Characterization of a Chromosomal Gene Encoding Type B β-Lactamase in Phage Group II Isolates ofStaphylococcus aureus , 1998, Antimicrobial Agents and Chemotherapy.

[12]  D. Kernodle,et al.  Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216 , 1996, Journal of bacteriology.

[13]  Francioli Pb.  Ceftriaxone and outpatient treatment of infective endocarditis. , 1993 .

[14]  W. Wilson,et al.  Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis , 1993, Antimicrobial Agents and Chemotherapy.

[15]  P. Francioli.  Ceftriaxone and outpatient treatment of infective endocarditis. , 1993, Infectious disease clinics of North America.

[16]  C. Stratton,et al.  Characterization of four beta-lactamases produced by Staphylococcus aureus , 1992, Antimicrobial Agents and Chemotherapy.

[17]  C. Stratton,et al.  Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants , 1990, Antimicrobial Agents and Chemotherapy.

[18]  W. Bruns,et al.  Extracellular and membrane-bound beta lactamase of Staphylococcus aureus: their importance for the expression of penicillin resistance. , 1987, Journal of medical microbiology.

[19]  Rosdahl Vt.  Penicillinase production in Staphylococcus aureus strains of clinical importance. , 1986 .

[20]  V. Rosdahl.  Penicillinase production in Staphylococcus aureus strains of clinical importance. , 1986, Danish medical bulletin.

[21]  R. Petersdorf,et al.  Importance of β-Lactamase Inactivation in Treatment of Experimental Endocarditis Caused by Staphylococcus aureus , 1980 .

[22]  R. Petersdorf,et al.  Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus. , 1980, The Journal of infectious diseases.

[23]  M. Laverdière,et al.  Use of a Heavy Inoculum in the In Vitro Evaluation of the Anti-Staphylococcal Activity of 19 Cephalosporins , 1978, Antimicrobial Agents and Chemotherapy.

[24]  R. Bryant,et al.  Unsuccessful treatment of staphylococcal endocarditis with cefazolin. , 1977, JAMA.

[25]  M. Finland,et al.  Effect of Inoculum and of Beta-Lactamase on the Anti-Staphylococcal Activity of Thirteen Penicillins and Cephalosporins , 1975, Antimicrobial Agents and Chemotherapy.

[26]  D. Pohlod,et al.  Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. , 1973, The Journal of infectious diseases.